Robert W. Baird analyst George Gianarikas reiterated a Buy rating on TuSimple Holdings (TSP – Research Report) on February 9 and set a price target of $28.00. The company’s shares closed last Friday at $16.47, close to its 52-week low of $14.92.
According to TipRanks.com, Gianarikas ‘ ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -17.4% and a 30.0% success rate. Gianarikas covers the Basic Materials sector, focusing on stocks such as Archer Daniels Midland, MP Materials, and Avient.
TuSimple Holdings has an analyst consensus of Strong Buy, with a price target consensus of $39.02, which is a 140.1% upside from current levels. In a report issued on February 10, Needham also maintained a Buy rating on the stock with a $54.00 price target.
Based on TuSimple Holdings’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $584K and GAAP net loss of $89.45 million. In comparison, last year the company earned revenue of $1.79 million and had a GAAP net loss of $115 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
TuSimple Holdings Inc is an autonomous technology company in the global truck freight market. It has developed a technology for semi-trucks to build the Autonomous Freight Network (AFN) in partnership with shippers, carriers, railroads, freight brokers, fleet asset owners, and truck hardware partners. The company recognizes revenue primarily from providing freight capacity services.
Read More on TSP:
- Robert W. Baird Thinks Decibel Therapeutics’ Stock is Going to Recover
- TELUS International (CDA) (TIXT) Gets a Hold Rating from Robert W. Baird
- BTIG Maintains a Buy Rating on ironSource (IS)
- Leerink Partners Thinks AbCellera Biologics’ Stock is Going to Recover
- Leerink Partners Thinks 4D Molecular Therapeutics’ Stock is Going to Recover